Covid-19 Vaccine Update: Gennova Pharmaceuticals Receives Permission to Study, US Considers Moderna Candidate Safe to Use

The global search for a vaccine to treat coronavirus disease (Covid-19) has entered a crucial phase with at least three countries – the United Kingdom, the United States and Canada – beginning to administer emergency fire. These are photos of the candidate for the Pfizer Inc-BioNTech SE vaccine, which has been approved for emergency use in other countries.

Click here for full coverage of Covid-19

Meanwhile, the overall number of Covid-19 cases is over 73 million, with over 1.6 million lives lost due to the virus, according to world meters. Nearly 52 million people have also overcome the disease, the balance sheet shows.

Here are the latest developments in the development of the Covid-19 vaccine:

1. Dr. VK Paul, a member of NITI Aayog, said on Tuesday that the Comptroller General of Medicines of India (DCGI) recently gave a nod to the phase 1 and 2 studies of the candidate for the Pune-based Genova Pharmaceuticals Limited vaccine. The company’s vaccine candidate, called HGCO19, is based on the same technology – mRNA – as that used by vaccine candidate Pfizer.

2. The US Food and Drug Administration (USFDA) said on Tuesday that the preliminary analysis confirmed the safety and efficacy of the Moderna vaccine candidate. A group of outside experts is likely to approve the vaccine on Thursday, and FDA approval will follow soon. The agency’s announcement came a day after vaccination of the Pfizer candidate began across the country.

3. Oman has joined the list of countries to allow the use of the Pfizer vaccine candidate, his state agency said on Tuesday. The vaccine, the local media, has been approved for use in people over the age of 16. Oman joins neighbors Bahrain, Kuwait and Saudi Arabia to allow the Pfizer candidate to be shot.

4. In an unusual move, Indonesia intends to vaccinate its young people in front of the elderly. The country will focus on vaccinating people between the ages of 18 and 59, starting with those working on the front line, such as health workers, police and the army.